Capricor Therapeutics CAPR Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Capricor Therapeutics's total equity?
- Capricor Therapeutics (CAPR) reported total equity of $278.7M in Q1 2026.
- How has Capricor Therapeutics's total equity changed year-over-year?
- Capricor Therapeutics's total equity increased by 118.3% year-over-year, from $127.65M to $278.7M.
- What is the long-term trend for Capricor Therapeutics's total equity?
- Over 5 years (2020 to 2025), Capricor Therapeutics's total equity has grown at a 61.1% compound annual growth rate (CAGR), from $28.2M to $305.79M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.